Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Microb Drug Resist ; 29(11): 533-539, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37733248

ABSTRACT

In recent years, increasing resistance of Bacteroides fragilis to several antibiotics has been reported in different countries. The aim of this study was to evaluate the antibiotic resistance profiles of Bacteroides spp. isolated from clinical samples by phenotypic and molecular methods. A total of 40 nonrepetitive isolates of the B. fragilis group were studied from 2018 to 2019. The species was identified by API 20A system. The minimum inhibitory concentrations (MICs) were determined by Sensititre anaerobe MIC plate. The presence of the nim and cfiA genes was checked by conventional PCR. The association between genes and insertion sequence (IS) was performed by whole genome sequencing. Eleven isolates were categorized as metronidazole-resistant and only 2 isolates harbored the nim gene. Five isolates were imipenem-resistant, but cfiA gene was detected in two isolates. cfiA gene was closely related to the cfiA-4 allele and associated with IS614B. The nim gene was not related to any nim gene type and was considered a new variant named nimL. IS612 was found upstream of nimL gene. In view of the scarcity of data on B. fragilis, there is a need to surveil antibiotic resistance levels and molecular mechanisms to implement better antimicrobial therapies against this important group of bacteria.


Subject(s)
Anti-Bacterial Agents , Bacteroides Infections , Humans , Anti-Bacterial Agents/pharmacology , Bacteroides , Bacteroides fragilis/genetics , Ecuador , beta-Lactamases/genetics , Bacteroides Infections/drug therapy , Bacteroides Infections/microbiology , Microbial Sensitivity Tests , Drug Resistance, Bacterial/genetics , Bacterial Proteins/genetics
4.
Neurol Int ; 14(2): 497-505, 2022 Jun 01.
Article in English | MEDLINE | ID: mdl-35736622

ABSTRACT

Background: Fabry disease (FD) is the second most common lysosomal storage disorder. This disorder affects multiple systems that include the cardiac, renal, and nervous system. The pulvinar sign (PS) is a relatively common sign seen in patients with FD. The PS is a bilateral, symmetrical pulvinar high signal relative to the signal intensity seen on unenhanced T1-weighted brain MR imaging. Methods: We conducted a systematic review with metanalysis to analyze the pool prevalence of the disorder. We used the Moose Guidelines and PRISMA Protocol for this systematic review and Robins 1 to access the BIAS of the study. To analyze the pool prevalence, we used "Open Meta-Analysis" software for analyzing the study. We used "Review Manager 5.4" to analyze the odds ratio between patients with and without the PS and patients with and without stroke among patients with FD. Results: We gather 12 studies from 2003 to 2021 for the analysis of this study. The pool prevalence of the study was 0.146 (0.076−0.217) (62/385 cases) with a 95% CI (0.0945−0.415) (p < 0.01). The prevalence was much higher in men (59 cases) than in women (3 cases). There was no relationship between the pulvinar sign and patients with stroke among patients with Fabry disease. Odds ratio 1.97 95% CI (0.35−11.21), p = 0.44; Tau2 = 0.77. There seems to be a correlation with renal failure (RF), but there were very few studies to conduct a metanalysis with RF. Conclusions: The prevalence of the PS among all studies was 23.9%; the prevalence of this sign is higher among males. We found that FD patients who had strokes did not have higher odds of presenting with the Pulvinar Sign than the FD patients who did not suffer a stroke. Patients with renal failure and FD seem to have a higher tendency to have the PS, but there were not enough studies to analyze that theory. Overall, we think the pulvinar sign has a poor prognostic value in patients with Fabry's disease.

5.
IDCases ; 28: e01494, 2022.
Article in English | MEDLINE | ID: mdl-35433266

ABSTRACT

We report a case of catheter-related bloodstream infection by Tsukamurella inchonensis, identified using 16S rRNA gene sequencing, in a patient with arterial hypertension for 20 years and chronic kidney disease in hemodialysis since 08/07/2019. To our knowledge, this is the first case of T. inchonensis in Ecuador.

6.
J Glob Antimicrob Resist ; 19: 216-221, 2019 12.
Article in English | MEDLINE | ID: mdl-31077859

ABSTRACT

OBJECTIVES: The purpose of this study was to describe the clonal relationships and phylogroups of extended-spectrum ß-lactamase-producing Escherichia coli (ESBL-Ec) isolated from patients with bacteraemia in three hospitals in Quito, Ecuador. METHODS: Between June 2013 and September 2014, a total of 4354 blood cultures were performed in three hospitals located in different areas of Quito. A BACTECTM system was used for blood culture, and the VITEK®2 system was used for species identification and in vitro antimicrobial susceptibility testing. The ESBL genotype, presence of the blaCTX-M, blaTEM and blaSHV genes, and the phylogenetic group of E. coli isolates was determined by PCR. Clonal groups were established by multilocus sequence typing (MLST). RESULTS: Of 929 blood cultures positive for Gram-negative bacilli, 181 (19.5%) were positive for E. coli, representing the most frequent bacteraemia isolates in each hospital. Of the 181 E. coli isolates, 57 (31.5%) were ESBL-Ec. The main sources of ESBL-Ec bacteraemia were urinary tract infection (40; 70.2%), biliary tract infection (10; 17.5%) and other infections (7; 12.3%). The majority of ESBL-Ec isolates (39; 68.4%) from the three hospitals belonged to the virulent phylogenetic group B2, of which 36/39 (92.3%) were ST131 and 33/36 (91.7%) carried the blaCTX-M-15 gene. CONCLUSION: These results provide knowledge of the phylogenetic relationships of E. coli from bacteraemia in Ecuadorian patients. ST131 has emerged in ESBL-Ec, representing an important public-health problem because this multiresistant clone is considered to be a vehicle for the propagation of antimicrobial resistance genes and is a highly virulent, well-adapted human pathogen.


Subject(s)
Bacteremia/epidemiology , Drug Resistance, Multiple, Bacterial , Escherichia coli Infections/epidemiology , Escherichia coli/drug effects , Escherichia coli/genetics , Phylogeny , Adult , Aged , Aged, 80 and over , Bacteremia/microbiology , Bacterial Typing Techniques , Ecuador/epidemiology , Escherichia coli/enzymology , Female , Genotype , Hospitals/statistics & numerical data , Humans , Male , Middle Aged , Multilocus Sequence Typing , Prevalence , beta-Lactamases/genetics
7.
Skinmed ; 16(3): 159-165, 2018.
Article in English | MEDLINE | ID: mdl-29989535

ABSTRACT

Antimicrobial resistance to Cutibacterium acnes has become a worldwide problem in the last century, but there are no previous studies on antibiotic susceptibility patterns of this bacterium in Ecuador. A total of 129 skin swabs were collected from patients with acne vulgaris (AV) attending the dermatology department of a hospital in Quito, Ecuador, from July to August 2015. The patients selected had received registered antimicrobial therapy on at least one occasion before sampling. Microbiological procedures were performed according to conventional methods. The species of isolates were identified using a mass spectrometer system (matrix-assisted laser desorption ionization time-offlight [MALDI-TOF]). Antibiotic susceptibility tests on isolated Cutibacterium were performed using an anaerobe-sensitive panel (ANO2; Thermo Fisher; TREK Diagnostic Systems Ltd., West Sussex, UK).


Subject(s)
Acne Vulgaris/microbiology , Anti-Bacterial Agents/therapeutic use , Drug Resistance, Microbial , Propionibacterium acnes/isolation & purification , Acne Vulgaris/drug therapy , Adolescent , Adult , Ecuador , Female , Humans , Male , Microbial Sensitivity Tests , Propionibacterium acnes/drug effects , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...